Incyte to Present at the 32nd Annual J. P. Morgan Healthcare Conference Business Wire WILMINGTON, Del. -- December 18, 2013 Incyte Corporation (Nasdaq:INCY) announced today it will present at the 32^nd Annual J. P. Morgan Healthcare Conference on Monday, January 13^th at 8:30 a.m. (PST) / 11:30 a.m. (EST) in San Francisco. The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com. Contact: Incyte Corporation Pamela M. Murphy Vice President, Investor Relations & Corporate Communications 302-498-6944
Incyte to Present at the 32nd Annual J. P. Morgan Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.